Latest News for: squibb
Edit
Black Hills Pioneer
01 May 2026
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
Edit
Bristol Myers Squibb Reports First Quarter Financial Results for 2026 (Bristol-Myers Squibb Company)
Public Technologies 30 Apr 2026
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE ... About Bristol Myers Squibb ... At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Edit
Bristol Myers Squibb Logs Higher Sales, Profit
Wall Street Journal 30 Apr 2026
Bristol Myers Squibb posted higher first-quarter revenue boosted by its portfolio of newer treatments for heart and blood conditions ... .
Edit
Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations
The Call 30 Apr 2026
Biopharmaceutical company Bristol Myers Squibb (NYSE ... Is now the time to buy Bristol-Myers Squibb? Find out by accessing our full research report, it’s free. Bristol-Myers Squibb (BMY) Q1 CY2026 Highlights..
Edit
Bristol Myers Squibb Reports First Quarter Financial Results for 2026 (Form 8-K) (Bristol-Myers Squibb Company)
Public Technologies 30 Apr 2026
Edit
Q1 2026 Results Presentation with Appendix (Bristol-Myers Squibb Company)
Public Technologies 30 Apr 2026
Edit
Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (Bristol-Myers Squibb Company)
Public Technologies 30 Apr 2026
Edit
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q1 Results Tomorrow
The Call 29 Apr 2026
Biopharmaceutical company Bristol Myers Squibb (NYSE ... Bristol-Myers Squibb beat analysts’ revenue expectations last quarter, reporting revenues of $12.5 billion, up 1.3% year on year ... Bristol-Myers Squibb is down 2.6% during the same time .
Edit
Psoriasis Market: Investment-Ready Growth Trends to 2034 – DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB ...
GetNews 29 Apr 2026
In February 2025, Bristol Myers Squibb (BMS), a US-based pharmaceutical company, announced results from the POETYK PSO long-term extension (LTE) trial evaluating Sotyktu (deucravacitinib) for plaque psoriasis.
Edit
Enid News & Eagle
24 Apr 2026
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus ...
Edit
Bristol Myers Squibb and Pfizer to Make Eliquis� (apixaban) Available via Mark Cuban Cost Plus ...
Business Wire 24 Apr 2026
Edit
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
Pharmiweb 24 Apr 2026
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Eliquis--The Bristol Myers Squibb-Pfizer (BMS NYSE ... About Bristol Myers Squibb ... About the Bristol Myers Squibb-Pfizer Collaboration ... Bristol Myers Squibb.
Edit
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
PR Newswire 23 Apr 2026
RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced today it has earned a $15 million development milestone payment from Bristol Myers Squibb (NYSE.
Edit
Sjogren's Syndrome Market Analysis Report 2025-2035 Featuring Novartis, Otsuka Pharmaceutical, Nicox, and Bristol Myers Squibb
Nasdaq Globe Newswire 22 Apr 2026
Key players like Novartis and Bristol Myers Squibb are enhancing research efforts ... Key players like Novartis and Bristol Myers Squibb are enhancing research efforts ... .
- 1
- 2
- Next page »